Battery Ventures completed the acquisition of Enzo Biochem for $37m.

Battery Ventures, a technology-focused investment firm, completed the acquisition of Enzo Biochem, a life-science research reagents company, for $37m. “This investment comes after years of tracking Enzo, whom we consider a leader in the research-reagents market. We’re excited to build on Enzo’s strong fundamentals and brand by helping the company develop new products, expand market share and pursue strategic acquisitions. Together, we’ll prioritize operational excellence and strive to deliver value to Enzo’s customers,” Justin Rosner, Battery Ventures Partner.